Microbiota medicine: towards clinical revolution

被引:135
作者
Gebrayel, Prisca [1 ]
Nicco, Carole [2 ,3 ]
Al Khodor, Souhaila [4 ]
Bilinski, Jaroslaw [5 ]
Caselli, Elisabetta [6 ]
Comelli, Elena M. [7 ]
Egert, Markus [8 ]
Giaroni, Cristina [9 ]
Karpinski, Tomasz M. [10 ]
Loniewski, Igor [11 ]
Mulak, Agata [12 ]
Reygner, Julie [13 ]
Samczuk, Paulina [14 ]
Serino, Matteo [15 ]
Sikora, Mariusz [16 ]
Terranegra, Annalisa [4 ]
Ufnal, Marcin [5 ]
Villeger, Romain [17 ]
Pichon, Chantal [18 ]
Konturek, Peter [19 ]
Edeas, Marvin [2 ,3 ]
机构
[1] Int Soc Microbiota, Tokyo, Japan
[2] Univ Paris, Dept Endocrinol Metab & Diabet, Fac Med Cochin Port Royal, INSERM U1016,Inst Cochin, 24 Rue Faubourg St Jacques, F-75014 Paris, France
[3] Lab Excellence GR Ex, Paris, France
[4] Sidra Med, Res Branch, Maternal & Child Hlth Dept, Doha, Qatar
[5] Med Univ Warsaw, Warsaw, Poland
[6] Univ Ferrara, Ferrara, Italy
[7] Univ Toronto, Toronto, ON, Canada
[8] Furtwangen Univ, Furtwangen, Germany
[9] Univ Insubria, Dept Med & Surg, Varese, Italy
[10] Poznan Univ Med Sci, Poznan, Poland
[11] Pomeranian Med Univ, Szczecin, Poland
[12] Wroclaw Med Univ, Wroclaw, Poland
[13] Univ Paris 05, Paris, France
[14] Med Univ Bialystok, Clin Res Ctr, Bialystok, Poland
[15] Univ Toulouse, IRSD, INSERM, INRAE,ENVT,UPS, Toulouse, France
[16] Natl Inst Geriatr Rheumatol & Rehabil, Warsaw, Poland
[17] Univ Clermont Auvergne, Clermont Ferrand, France
[18] Univ Orleans, Ctr Mol Biophys CNRS UPR 4301, Orleans, France
[19] Univ Jena, Teaching Hosp, Jena, Germany
关键词
Dysbiosis; Built environment microbiome; Metabolites; miRNAs; Fecal microbiota transplant; Prebiotics; Probiotics; Oral microbiota; Metabolic syndrome; GUT-MICROBIOTA; BUILT ENVIRONMENT; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; COLONIZATION; MECHANISMS; DISEASE; PROBIOTICS; DYSBIOSIS; HEALTH;
D O I
10.1186/s12967-022-03296-9
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The human gastrointestinal tract is inhabited by the largest microbial community within the human body consisting of trillions of microbes called gut microbiota. The normal flora is the site of many physiological functions such as enhancing the host immunity, participating in the nutrient absorption and protecting the body against pathogenic microorganisms. Numerous investigations showed a bidirectional interplay between gut microbiota and many organs within the human body such as the intestines, the lungs, the brain, and the skin. Large body of evidence demonstrated, more than a decade ago, that the gut microbial alteration is a key factor in the pathogenesis of many local and systemic disorders. In this regard, a deep understanding of the mechanisms involved in the gut microbial symbiosis/dysbiosis is crucial for the clinical and health field. We review the most recent studies on the involvement of gut microbiota in the pathogenesis of many diseases. We also elaborate the different strategies used to manipulate the gut microbiota in the prevention and treatment of disorders. The future of medicine is strongly related to the quality of our microbiota. Targeting microbiota dysbiosis will be a huge challenge.
引用
收藏
页数:20
相关论文
共 250 条
  • [1] Abdallah F., 2017, MEDIATORS INFLAMM, V2017, P89
  • [2] Gut microbiota-derived metabolites as central regulators in metabolic disorders
    Agus, Allison
    Clement, Karine
    Sokol, Harry
    [J]. GUT, 2021, 70 (06) : 1174 - 1182
  • [3] Western diet induces a shift in microbiota composition enhancing susceptibility to Adherent-Invasive E. coli infection and intestinal inflammation
    Agus, Allison
    Denizot, Jeremy
    Thevenot, Jonathan
    Martinez-Medina, Margarita
    Massier, Sebastien
    Sauvanet, Pierre
    Bernalier-Donadille, Annick
    Denis, Sylvain
    Hofman, Paul
    Bonnet, Richard
    Billard, Elisabeth
    Barnich, Nicolas
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [4] Gut microbiome and kidney disease: a bidirectional relationship
    Al Khodor, Souhaila
    Shatat, Ibrahim F.
    [J]. PEDIATRIC NEPHROLOGY, 2017, 32 (06) : 921 - 931
  • [5] Role of gut microbiota in liver disease
    Albhaisi, Somaya A. M.
    Bajaj, Jasmohan S.
    Sanyal, Arun J.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2020, 318 (01): : G84 - G98
  • [6] Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches
    Alshehri, Dikhnah
    Saadah, Omar
    Mosli, Mahmoud
    Edris, Sherif
    Alhindi, Rashad
    Bahieldin, Ahmed
    [J]. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (03) : 270 - 283
  • [7] Probiotics, prebiotics and colorectal cancer prevention
    Ambalam, Padma
    Raman, Maya
    Purama, Ravi Kiran
    Doble, Mukesh
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (01) : 119 - 131
  • [8] [Anonymous], Google Patents, Patent No. [EP3666905A1, 3666905]
  • [9] [Anonymous], 2021, Google Patents, Patent No. [WO2017103225A1, 2017103225]
  • [10] Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response
    Antunes, Krist Helen
    Fachi, Jose Luis
    de Paula, Rosemeire
    da Silva, Emanuelle Fraga
    Pral, Lais Passariello
    dos Santos, Adara Aurea
    Malaquias Dias, Greicy Brisa
    Vargas, Jose Eduardo
    Puga, Renato
    Mayer, Fabiana Quoos
    Maito, Fabio
    Zarate-Blades, Carlos R.
    Ajami, Nadim J.
    St Ana, Marcella Ramos
    Candreva, Thamiris
    Rodrigues, Hosana Gomes
    Schmiele, Marcio
    Pedrosa Silva Clerici, Maria Teresa
    Proenca-Modena, Jose Luiz
    Vieira, Angelica Thomas
    Mackay, Charles R.
    Mansur, Daniel
    Caballero, Mauricio T.
    Marzec, Jacqui
    Li, Jianying
    Wang, Xuting
    Bell, Douglas
    Polack, Fernando P.
    Kleeberger, Steven R.
    Stein, Renato T.
    Ramirez Vinolo, Marco Aurelio
    Duarte de Souza, Ana Paula
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)